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ABSTRACT
Methylation of DNA at carbon 5 of cytosine is es-
sential for mammalian development and implicated
in transcriptional repression of genes and trans-
posons. New patterns of DNA methylation charac-
teristic of lineage-committed cells are established at
the exit from pluripotency by de novo DNA methyl-
transferases enzymes, DNMT3A and DNMT3B, which
are regulated by developmental signaling and require
access to chromatin-organized DNA. Whether or not
the capacity for de novo DNA methylation of devel-
opmentally regulated loci is preserved in differenti-
ated somatic cells and can occur in the absence of
exogenous signals is currently unknown. Here, we
demonstrate that fibroblasts derived from chromatin
remodeling ATPase LSH (HELLS)-null mouse em-
bryos, which lack DNA methylation from centromeric
repeats, transposons and a number of gene pro-
moters, are capable of reestablishing DNA methyla-
tion and silencing of misregulated genes upon re-
expression of LSH. We also show that the ability
of LSH to bind ATP and the cellular concentration
of DNMT3B are critical for cell-autonomous de novo
DNA methylation in somatic cells. These data sug-
gest the existence of cellular memory that persists
in differentiated cells through many cell generations
and changes in transcriptional state.
INTRODUCTION
Methylation ofDNAat the fifth carbon of cytosine (5mC) is
an abundant epigenetic modification in vertebrate genomes
(1). In mammals, DNA methylation is established during
development and contributes to regulation of genomic im-
printing, tissue-specific gene expression, silencing of retro-
transposons and X chromosome inactivation in females
(2,3). The deposition of new methyl groups to cytosine
occurs by the action of two homologous enzymes, the de
novo DNA methyltransferases DNMT3A and DNMT3B,
while the propagation of 5mC through DNA replication re-
quires the activity of maintenance DNA methyltransferase
DNMT1 (4). DNMTs are critical in early mammalian de-
velopment when, following a nearly global erasure of 5mC
during the cleavage stages of pre-implantation embryo, new
patterns of 5mC are established post-implantation in the
developing epiblast (E6.5) (3,5,6). Embryos lacking either
DNMT1 or DNMT3B display severe 5mC deficiency and
die at mid-gestation (E9.5–E11) (7,8). Several studies have
identified DNMT3B as the main enzyme responsible for
de novoDNAmethylation during development (6,8–10). In
Dnmt3b−/− embryos, the centromeric repeats, promoters
of germ cell-specific genes and genes on the inactive X chro-
mosome in female embryos remain hypomethylated.
The occurrence of new methylation at specific time of de-
velopment suggests that the levels and the activity of DN-
MTs must be tightly controlled and coupled to develop-
mental signaling. Several signal transduction pathways, in
particular FGF and WNT, have been implicated in the exit
frompluripotency, priming of embryonic cells for differenti-
ation and regulation of DNAmethylation. Thus simultane-
ous inhibition ofmitogen-activated protein kinase (MAPK)
and glycogen synthase kinase 3 (GSK3) pathways by spe-
cific inhibitors (2i) reinforces the naı¨ve pluripotency of em-
bryonic stem (ES) cells and this is accompanied by rapid
downregulation of DNMT3B and loss of 5mC (11–13).
In addition to developmental signaling, the activity of
DNMTs is also regulated at the level of chromatin. Un-
like DNMT1 that methylates newly replicated hemimethy-
lated DNA largely devoid of nucleosomes, the DNMT3 en-
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zymes must function on DNA organized into chromatin.
In comparison to naked DNA, stably positioned nucleo-
somes are a poor substrate for de novo DNA methylation
in vitro and partly in vivo (14,15). Therefore the efficient de
novomethylation of chromatin-organized DNA in cells and
embryos requires either dynamic repositioning of nucleo-
somes or loosening of the contacts between the histones
and DNA. In agreement with this, several ATP-dependent
chromatin remodeling enzymes have been implicated in the
regulation of 5mC levels and patterns, including the mam-
malian SNF2 family ATPases ATRX and LSH (16,17). A
knockout of Lsh (Hells) gene in mice results in ∼50% re-
duction of the global 5mC in the genome affecting repeti-
tive sequences and large chromosomal domains associated
with the nuclear lamina (16,18,19).Mapping of 5mC at pro-
moters of protein-coding genes in wild-type and Lsh−/−
mouse embryonic fibroblasts (MEFs) detected loss of 5mC
from 20% of normally methylated promoters (19), many of
which undergo lineage-specific silencing and de novo DNA
methylation during early mouse development (10). Impor-
tantly, many of these genes are inappropriately expressed
in the Lsh−/− MEFs (19). As DNMTs are present at nor-
mal levels in LSH-deficient cells (16) and LSH interacts
directly with DNMT3B (20), these findings suggest that
ATP-dependent chromatin remodeling is critical during de-
velopment to open up chromatin for developmentally pro-
grammed DNA methylation by de novo enzymes.
If the programmed de novoDNAmethylationwere tightly
regulated by signaling pathways in the developing embryo,
one would predict that the loss of 5mCwould be irreversible
in somatic cells taken out of their normal developmental
context. In order to investigate whether this is the case, we
restored the expression of LSH in spontaneously immor-
talized hypomethylated Lsh−/− MEFs grown in culture
for many cell generations. Contrary to our expectations, we
found that 5mC at repetitive and unique sequences as well
as gene silencing of developmentally regulated loci could
be substantially reestablished when a wild-type LSH pro-
tein was introduced into the Lsh−/− MEFs. We also found
that the reversal of 5mC levels and patterns in the Lsh−/−
MEFs required the catalytic activity of LSH ATPase and
appropriate cellular concentration of DNMT3B. Taken to-
gether, these experiments demonstrate that the capacity for
LSH-regulated de novo DNA methylation of repetitive se-
quences and transcriptionally active developmentally regu-
lated promoters is preserved in somatic cells. These experi-
ments also suggest the existence of epigenetic cellular mem-
ory, which persists through changes in transcriptional state
and permits silencing of inappropriately expressed genes
and repetitive sequences in the absence of developmental
signaling.
MATERIALS AND METHODS
Cell culture
All mouse embryonic fibroblast cell lines were grown
in DMEM (Sigma) supplemented with 10% fetal bovine
serum (Thermo Fisher), 100 units/ml penicillin, 1 mg/ml
of streptomycin and 2 mM L-glutamine.
Establishment of stable cell lines
pMSCV-LSH and pMSCV-K237Q plasmids were gen-
erated by cloning into pMSCV vectors carrying ei-
ther puromycin or hygromycin resistance marker of
mouse synthetic LSH ORF (wild-type and mutant; Life
Technologies/GeneART) designed to contain an in-frame
C-terminal 3xFLAG tag followed by the 3′UTR and
polyadenylation sequence of the LSH mRNA. pMSCV,
pMSCV-LSH and pMSCV-K237Q plasmids were pack-
aged into lentiviral particles in Phoenix A cells. Culture
supernatants were harvested 48 h post-transfection and
the lentiviral titres determined by infection of NIH-3T3
mouse fibroblasts. 3 × 105 Lsh−/− MEFs were infected
with lentiviral particles at MOI = 1 in the presence of
4 g/ml Polybrene. The cells were transferred to larger
dishes 48 h post-infection and selected with 2.5 g/ml
puromycin for 7–10 days. Individual colonies were isolated
and expanded into cell lines. DNMT3B was knocked down
by infecting the Lsh−/− MEFs with packaged lentivi-
ral particles (Thermo Scientific) carrying pGIPZ plasmids
with either non-silencing shRNAmir (V3LMM 420607) or
shRNAmir sequences targeting murine DNMT3B mRNA
(V2LMM 257108; V2LMM 257108; V2LMM 53727) at
MOI = 3 in the presence of 4 g/ml Polybrene. The cells
were selected with 2.5 g/ml puromycin for 7–10 days
and subsequently infected with lentiviral particles carrying
pMSCV-LSH-hygro at MOI = 1. The cells were selected
with 400 g/ml hygromycin and single colonies expanded
into cell lines.
Western blots
Nuclear extracts were prepared as described (19) and 60 g
of each extract were resolved in 7% SDS-polyacrylamide
gel. The gels were transferred to nitrocellulose membrane
(BioRad), blocked with 4% skimmedmilk in 1×TBS; 0.1%
Tween and incubated with primary antibodies in block-
ing solution overnight. The membranes were washed exten-
sively with PBS; 0.1% Tween, re-blocked for 30 min and in-
cubated with secondary anti-mouse IR-800 and anti-rabbit
IR-670LT antibodies (LiCOR Biosciences) for 1 h. After
washing with PBS; 0.1% Tween, the membranes were im-
aged on Odyssey scanner (LiCOR Biosciences) and quan-
tified when required with Image Studio Software (LiCOR
Biosciences). The primary antibodies used for Western
blots were: anti-LSH (Santa Cruz; sc-46665), anti-Flag M2
(Sigma), anti-MRE11 (Calbiochem; PC388), anti-HDAC1
(Santa Cruz; sc-7872) and anti-DNMT3B (Thermo Fisher;
AFPA1884).
Southern blots
Genomic DNA was purified from MEF cell lines using
standard protocols and 10 g of each DNA were digested
with either MspI or its methylation-sensitive isoschizomer
HpaII for 3 h at 37◦C. DNA was resolved on 1% Agarose
gels run in 1 × TAE buffer, the gels were transferred
to nitrocellulose membrane (Pall B; VWR) with 0.4 M
NaOH and hybridized with minor-satellite probe labeled
with -P32-dCTP (Perkin Elmer) by a random-priming kit
(Thermo Scientific) in buffer containing 1 mM EDTA, 0.5
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MNaHPO4 and 7% SDS at 65◦C overnight. The blots were
subsequently washed with 3× SSC; 0.1% SDS at 65◦C and
imaged on Typhoon phosphorimager (GE Healthcare).
Bisulfite DNA sequencing
For bisulfite DNA sequencing, genomic DNA was pro-
cessed with EpiTect Bisulfite conversion kit (QIAGEN) and
used as a template for PCRs with specific primer pairs,
which are listed in Supplementary Table S1. PCR products
were cloned into pJet vector (Thermo Scientific) and se-
quenced using a reverse pJet primer and BigDye sequenc-
ing mix (Applied Biosystems). Sequences were analyzed by
BiQ Analyzer software (21).
Analyses of DNA methylation by reverse-phase HPLC
DNA was extracted from ESCs following standard proto-
cols and residual RNA was removed by enzymatic hydrol-
ysis (6-hour incubation with RNase A and RNase T1) fol-
lowed by DNA precipitation in 3 volumes of ethanol. This
was repeated once. 1–5 g of purified DNA was digested
with DNase1 (New England Biolabs) for 12 h in the recom-
mended buffer. Following this, 2 volumes of 30 mM sodium
acetate pH 5.2 was added and the DNA was further di-
gested to nucleotide 5′ monophosphates with Nuclease P1
(Sigma) in the presence of 1 mM zinc sulphate (7-h incu-
bation). The quantitation of 5-methylcytosine in genomic
DNA was performed in triplicate by isocratic high perfor-
mance reverse phase liquid chromatography as previously
described (22), with the following alterations. A Dionex
UM 3000 HPLC system was used complete with a column
chiller, C18 column (250 mm × 4.6 mm 5 um APEX ODS,
#4M25310, Grace Discovery Sciences), and column guard
(Phomenex, #AJ0-7596). Themobile phase was 50mMam-
momium phosphate (monobasic) pH4.1. The column was
chilled to 8◦C to improve peak separation. Deoxyribonu-
cleotides (dNMPs)were detected at their extinctionmaxima
using a Dionex 3000 multiple wavelength detector: dCMP,
276 nm; 5mdCMP, 282 nm. Quantifications were calculated
from the area under each peak using the respective extinc-
tion coefficients (dCMP, 8.86 × 103; 5mdCMP 9.0 × 103).
Quantitative RT-PCR
Total RNA was purified from cell lines using TRIzol
reagent (Life Technologies) according to manufacturer’s in-
structions and cDNA synthesis performed with Superscript
II (Life Technologies). Quantitative reverse transcription
PCRs were carried out in three biological replicates with six
technical replicates for each with SYBR-Green Mastermix
(Roche) on Roche LC480 instrument. Fold changes relative
to GAPDH were calculated using the Pfaffl method (23).
Primer sequences are listed in Supplementary Table S1.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed essentially
as described in (19). Briefly, the cells were crosslinked
with 1% formaldehyde in DMEM supplemented with 10×
crosslinking buffer (500 mM HEPES, pH7.9; 1.5 M NaCl;
10 mM EDTA; 5 mM EGTA), to 1× final concentration.
After neutralising the formaldehyde with 2.5 M glycine (fi-
nal concentration 125 mM), the cells were spun at 1200 rpm
at 4◦Candwashedwith PBS supplementedwith PMSF. The
crosslinked cells were resuspended and incubated in buffer
L1 (50 mMHEPES, pH 7.9; 140 mMNaCl; 1 mM EDTA;
10% glycerol; 0.5% NP-40; 0.25% Triton X-100) for 5 min,
spun and resuspended in buffer L2 (10 mM Tris pH 8; 200
mM NaCl; 1 mM EDTA; 0.5 mM EGTA). After incuba-
tion for 5 min, the cells were spun again, resuspended in
TE with 0.3% SDS at density 4 × 106 cells/ml and sheared
with BioRuptor sonicator (Diagenode) to fragments of av-
erage size 250–300 bp. 10 g of chromatin were used per
IP with 4 g of either rabbit anti-H3K4me3 antibody (Ac-
tiveMotif) or control rabbit IgG. IP washes were performed
as described elsewhere (19). After descrosslinking, immuno-
precipitated DNA was purified with PureLink kit (Thermo
Fisher) and 1/50 of input and ChIP DNA were used in
each 20 l quantitative PCR reaction. ChIP experiments
were performed in two biological replicates with six techni-
cal replicates for each. Primers are listed in Supplementary
Table S1.
MeDIP sequencing and data analyses
MeDIP was performed essentially as described (24) with
anti-5mC antibody (Eurogentec) on genomic DNA soni-
cated to average fragment size 300 bp. Ligation of Illumina
adaptor sequences was performed prior to MeDIP with
NEB-next DNA library Mastermix Set and Singleplex Il-
lumina adaptor oligos (NEB) according to manufacturer
instructions. After MeDIP, the DNA was amplified with
14 cycles of PCR and size selected on agarose gel for frag-
ments 250–350 bp. The resulting libraries were Single-end
sequenced on Illumina HiSeq2000 instrument generating
120–140 million reads per sample 99% of which could be
mapped to the mouse genome. The MeDIP-seq reads were
mapped with Burrows Wheeler Algorithm mem version
0.7.5a to the mm10 genome assembly. Sam files were pro-
cessed into bam files using samtools version 0.1.19. Count
tables for each of the studied regions were created using the
coverage program in version 2.17.0 of the bedtools suite.
Count tables were first normalized to raw reads per kilo-
base of feature, and then normalized to regions that were
previously shown not to change DNAmethylation between
wild-type and Lsh−/− MEFs (19). A linear regression line
of the log2 read counts of these non-changing regions was
calculated, and the whole dataset was transformed such so
that the line would have an intercept of 0 and a gradient of 1.
A script written in R (normalise2file.r) can be downloaded
from https://github.com/AlastairKerr/Termanis2015. Data
was plotted using the ggplot2 package in R. Methylation
recovery (MR) was calculated as MR = [100 x (log2D –
log2S)]/D where D = log2 read count WT - log2 read count
MSCV and S denotes the log2 read count for each of the
cell lines expressing either LSH or K237Q. TheMeDIP-seq
data can be accessed at NCBI GEO database using acces-
sion number [GEO: GSE64384].
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RESULTS
Lsh−/− MEFs expressing wild-type LSH display an in-
crease in 5mC and methylate repetitive sequences
To investigate if the reduced levels of 5mC and the misex-
pression of normally silenced loci (genes and retrotrans-
posons) are reversible in the Lsh−/− MEFs and if such
reversal requires the catalytic activity of LSH, we intro-
duced by lentiviral transduction a triple FLAG (3xFLAG)-
tagged full length LSH, either wild-type or ATP binding-
deficient mutant (25), carrying lysine 237 mutated to glu-
tamine (K237Q), into the Lsh−/− MEFs. As an additional
control, we also infected the LSH-null cells with viral par-
ticles carrying an empty vector (pMSCV). As the lentivi-
ral vector carries puromycin resistancemarker, we subjected
the transduced cells to selection and subsequently isolated
stable clonal cell lines (Figure 1A). For convenience, we will
refer to these cell lines as Lsh−/− LSH, Lsh−/− K237Q
and Lsh−/−MSCV. QuantitativeWestern blots (Figure 1B
and C) and immunostaining with anti-FLAG antibodies
(Figure 1D) revealed that most cell lines, except Lsh−/−
MSCV, stably expressed either the wild-type or mutant
LSH, although at different levels, and displayed a relatively
homogeneous distribution of the 3xFLAG-LSH through-
out the nucleus. We selected four cell lines, two expressing
the wild-type LSH (Figure 1B and C, labeled 1 and 3) and
two expressing theK237Qmutant (Figure 1B andC, labeled
3 and 4), for further analyses.
To examine if the expression of either LSH or K237Q
in the Lsh−/− MEFs led to detectable changes in DNA
methylation, we analyzed by High Performance Liquid
Chromatography (HPLC) the total amount of 5mC inDNA
purified from the clonal cell lines and compared the values
with those of the controls, Lsh−/− MSCV and wild-type
MEFs. The HPLC analyses detected a significant increase
(∼25%) of 5mC in both Lsh−/− LSH cells lines compared
to Lsh−/− MSCV, but not in the Lsh−/− K237Q cell lines
(Figure 2A). These data suggest that the wild-type LSH,
but not the catalytically inactive K237Q mutant, promotes
de novo DNA methylation in the Lsh−/− MEFs although
both proteins and DNMT3B displayed comparable associ-
ation with chromatin (Supplementary Figure S1).
DNA methylation of most repetitive sequences, includ-
ing minor (centromeric) and major (pericentric) satellite re-
peats, IAP retrotransposons and LINE elements, is LSH-
dependent (26) (Figure 2B and C, compare WT with
MSCV) and some of these sequences are transcribed in the
Lsh−/−, but not in wild-type MEFs (27,28). To investigate
further the patterns of DNA methylation in the Lsh−/−
MEFs with restored LSH expression, we analyzed DNA
methylation at specific repetitive sequences. Southern blots
on DNA digested with methylation sensitive HpaII restric-
tion enzyme hybridized with minor satellite probe detected
the characteristic ladder of hypomethylated satellite repeats
inLsh−/−MSCVMEFs and in three independentLsh−/−
K237Q cell lines (Figure 2B). This laddering was largely ab-
sent in HpaII-digested DNA derived from Lsh−/− LSH
cell lines (Figure 2B). Interestingly, there was no significant
correlation between the efficiency of methylation at satellite
sequences and the expression levels of wild-type LSH in the
Lsh−/− cell lines (Compare Figure 1B and C with Figure
2B). Furthermore, bisulfite DNA sequencing of IAP retro-
transposons detected a significant 20–40% increase in DNA
methylation in the Lsh−/− LSH cell lines, while methyla-
tion of IAPs in Lsh−/− K237Q cells was comparable to
that of the MSCV control (Figure 2C). Collectively, these
analyses demonstrate that the Lsh−/− somatic cells are ca-
pable of efficient de novoDNAmethylation of repetitive se-
quences upon expression of wild-type LSH, but not of the
catalytically-inactive K237Q mutant.
De novo gene silencing and DNAmethylation in the Lsh−/−
MEFs require LSH, but can occur in the absence of differen-
tiation signals
As mentioned earlier, about 20% of all promoters normally
methylated in wild-type MEFs lack DNA methylation in
the Lsh−/− MEFs (19). Among these are the promoters
of reproductive homeobox (Rhox) genes and pluripotency-
associated genes (Dppa2 and Dppa4), which undergo
transcriptional silencing and programmed DNMT3A/3B-
dependent de novoDNAmethylation during early develop-
ment in cells that contribute to the embryo proper (10,29).
Normally, the Rhox genes are expressed and their promot-
ers are not methylated in extraembryonic tissues and in
germ cells, but are stably silenced and methylated in the em-
bryo and all somatic cells (10,30). The vast majority ofRhox
genes are hypomethylated and expressed in Lsh−/−MEFs,
but not in their wild-type counterparts (19).
Given that the 5mC at the Rhox loci, including promot-
ers, is established early in development following the speci-
fication of embryonic and extraembryonic lineages (10), we
asked whether or not the Lsh−/− MEFs could methylate
and silence these genes in the absence of exogenous signals.
Surprisingly, bisulfite DNA sequencing detected an almost
complete methylation of Rhox2a, Rhox6 and Rhox9 pro-
moters in Lsh−/− LSH cell lines, while DNA methylation
was absent in Lsh−/− K237Q and Lsh−/− MSCV cells
(Figure 3).De novoDNAmethylation of gene promoters in
the Lsh−/− LSH cell lines was also accompanied by robust
silencing ofRhox as well as other LSH-dependent loci, such
as Gm9 and IAP retrotransposons (Figure 4A). Transcrip-
tional silencing and de novoDNAmethylation of gene pro-
moters in the Lsh−/− LSH cells were also accompanied by
loss of histone H3 lysine 4 trimethylation (H3K4me3) (Fig-
ure 4B), a histone modification that marks active promoters
and CpG islands in mammalian cells (31,32). None of the
examined genes were silenced and often showed a mild in-
crease in expression and H3K4me3 in the Lsh−/− K237Q
MEFs (Figure 4A and B). In contrast to the Rhox loci, we
did not observe silencing of HoxC6, Peg12 and pluripo-
tency genes Dppa2 and Dppa4 (Figure 4A). The promoters
of Dppa2 and Dppa4 remained unmethylated in Lsh−/−
LSH cells (Supplementary Figure S2A and B) suggesting
that additional signals might be required for silencing and
de novoDNAmethylation of these loci. However, treatment
of Lsh−/− LSH and Lsh−/− K237Q MEFs with retinoic
acid induced silencing of Dppa2 and Dppa4 and methyla-
tion of promoter sequences, but this repression could not be
stably maintained in Lsh−/− K237Q MEFs (Supplemen-
tary Figure S2C and D).
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Figure 1. Generation of stable Lsh−/− MEF cell lines expressing either wild-type or catalytically inactive LSH. (A) Schematic diagram showing the
generation of stable cell lines from theLsh−/−MEFs by lentiviral transduction of packaged pMSCVvectors. (B) Expression of thewild-type LSHandATP
binding-deficientmutant form,LSHK237Q (K237Q), in clonal cell lines. QuantitativeWestern blotswere probedwith the indicated antibodies.MRE11was
used as a loading control. (C) Quantification of the wild-type and mutant 3xFLAG-tagged LSH protein levels in clonal cell lines. (D) Immunofluorescence
staining of stable cell lines with anti-FLAG antibody. The nuclei were counterstained with DAPI. The scale bar corresponds to 20 m.
Taken together, our analyses demonstrate that, in addi-
tion to repetitive sequences, the Lsh−/− LSH MEFs are
capable of efficient silencing and de novomethylation of ac-
tive, H3K4me3-marked developmentally regulated promot-
ers and that these events require ATP hydrolysis by LSH
and can take place in the absence of exogenous signals.
The catalytic activity of LSH supports de novo DNA methy-
lation by both DNMT3 enzymes
As the expression of wild-type LSH in the Lsh−/− MEFs
restored the 5mC levels from 52% to ∼ 75% of those
measured in wild-type MEFs (Figure 2A), we next asked
whether or not the Lsh−/− LSH MEF cell lines displayed
heterogeneity of DNA methylation patterns and if DNA
methylation was restored uniformly across the genome. To
address these questions, we carried out methylated DNA
immunoprecipitation (24) followed by high-throughput se-
quencing (MeDIP-seq) on DNA purified from wild-type
MEFs, Lsh−/− MSCV, Lsh−/− LSH (lines 1 and 3) and
Lsh−/− K237Q (lines 3 and 4). The obtained reads were
aligned to the genome and analyzed further. A visual in-
spection of DNA methylation patterns at specific loci, for
example the Rhox cluster of homeobox genes (Figure 5A),
and pairwise comparisons between the samples (Figure
5B) revealed that the DNA methylation patterns of both
Lsh−/− LSH cell lines were very similar to each other and
resembled those of the wild-type MEFs. As expected, the
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Figure 2. Wild-type LSH restores DNA methylation globally and at repetitive sequences in Lsh−/− MEFs. (A) Quantification of 5mC by HPLC in
indicated cell lines. To simplify the comparison, the amount of 5mC in wild-type MEFs (3.3% of total cytosine) is represented as 100%. Error bars
represent standard deviation, n = 3, P values (t-test) **** is P < 10−4 and *** is P < 10−3. (B) Southern blots of either HpaII (methylation sensitive) or
MspI (methylation insensitive) restriction enzymes-digested genomic DNA from indicated cell lines hybridized with 32P-labeled centromeric mouse minor
satellite probe. (C) Bisulfite DNA sequencing of IAP retrotransposons in indicated cell lines. Each row represents a single DNA strand, and each circle is
a CpG dinucleotide. Methylated CpGs are shown in black.
patterns of 5mC of the Lsh−/− K237Q cell lines showed
the highest correlation with each other and the Lsh−/−
MSCV cells. This suggests that the expression of LSH in
the Lsh−/− MEFs results in a relatively uniform, although
incomplete (Figures 2C and 3), de novomethylation of LSH-
dependent loci.
In ES cells, DNMT3B is recruited to chromatin via
binding to H3K36me3, a modification established co-
transcriptionally in gene bodies, while DNMT3A displays
a more broad distribution across the genome, which posi-
tively correlates with CpG density (15). In addition, both
DNMT3A and DNMT3B, are capable of interacting with
the unmodified histone H3 tails via a conserved ADD
domain (33–35). Similar to ES cells, the calculated mean
methylation of gene bodies in wild-type MEFs was higher
than the median DNA methylation in the intergenic re-
gions (Supplementary Figure S2A,WT) andmethylation of
both types of sequences was reduced proportionally in the
Lsh−/− MEFs (Supplementary Figure S3A, MSCV).
To assess further if LSH supports de novo methylation
by both DNMT3 enzymes, we calculated the mean DNA
methylation recovery in gene bodies and intergenic regions
for the Lsh−/− LSH and Lsh−/− K237Q cells (see Meth-
ods). The calculated recovery of DNAmethylation was 40–
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Figure 3. De novoDNAmethylation of developmentally-regulated gene promoters inLsh−/−MEFs expressing wild-type LSH. Bisulfite DNA sequencing
of reproductive homeobox (Rhox) gene promoters in wild-type MEFs, Lsh−/− MEFs carrying an empty pMSCV vector and Lsh−/− MEFs expressing
either wild-type or mutant LSH. The numbers below the promoter graphs indicate bp upstream (−) or downstream (+) from the transcription start site.
Each row of circles is a single DNA strand and methylated CpGs are shown in black.
80% for both types of regions with higher median value for
gene bodies than intergenic regions (Figure 5D). Interest-
ingly, we also detected a weak, but consistent recovery of
DNA methylation in the Lsh−/− K237Q cell lines (Fig-
ure 5D and Supplementary Figure S3). In contrast to wild-
type LSH, the median recovery values for intergenic regions
were higher than those for gene bodies in LSH K237Q ex-
pressing cells (Figure 5D). This indicates that although both
DNMT3 enzymes require the catalytic activity of LSH for
efficient de novo DNA methylation, the chromatin remod-
eling by LSH plays a more significant role in DNMT3B-
rather than in DNMT3A-dependent methylation.
Consistent with the bisulfite sequencing data for IAPs
and Rhox promoters (Figures 2 and 3), DNA methyla-
tion was also restored with 3–4 fold higher efficiency at all
classes of repetitive sequences and gene promoters in the
Lsh−/−LSH cell lines in comparisonwithLsh−/−K237Q
cells (Figure 5C, E and Supplementary Figure S3B). Over-
all, 96% of all promoters that were hypomethylated in the
Lsh−/−MEFs substantially recovered 5mC in theLsh−/−
LSH cell lines (Supplementary Figure S3B and C). Taken
together, these data support our global and locus-specific
analyses of DNAmethylation (Figures 1 and 2) and demon-
strate that upon LSH expression in the Lsh−/− MEFs de
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Figure 4. The Lsh−/− MEFs expressing wild-type LSH efficiently silence IAP retrotransposons and developmentally regulated genes. (A) Expression
of IAP retrotransposons and specific genes in wild-type MEFs, Lsh−/− MEFs carrying an empty pMSCV vector and Lsh−/− MEFs expressing either
wild-type or mutant LSH as assessed by quantitative RT-PCR. The bar graphs show fold change in expression relative to Lsh−/− MSCV MEFs. The
housekeeping Gapdh gene was used for normalisation. The fold upregulation of gene expression detected by qRT-PCR in Lsh−/− MSCV relative to
wild-type MEFs is shown numerically above the brackets. The error bars represent standard deviation. (B) Silencing of gene expression by wild-type LSH
is accompanied by loss of H3K4me3 from gene promoters. Tnfsf9 was randomly chosen from the list of promoters that aquire DNA methylation in the
Lsh−/− LSH cells. The error bars represent standard deviation. A rabbit IgG was used as additional control for the anti-H3K4me3 antibody (not shown).
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novo DNMTs are able to access genic, intergenic and pro-
moter sequences.
DNMT3B is necessary for de novo DNA methylation and si-
lencing of LSH-dependent loci
DNA methyltransferase DNMT3B is implicated in the es-
tablishment of DNA methylation in post-implantation em-
bryos (6,9) as well as in de novo methylation of the Rhox
loci (10) and centromeric repeats (8). As LSH directly in-
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Figure 6. DNMT3B is required for de novo DNA methylation of IAPs and gene promoters upon LSH expression in Lsh−/− MEFs. (A) Expression
of DNMT3B in Lsh−/− MEFs expressing either a non-silencing shRNA (shNS) or shRNAs (sh1, sh2 and sh3) targeting DNMT3B as assessed by
quantitative RT-PCR. The error bars denote standard deviation. (B) Western blots showing the presence of 3xFLAG-tagged wild-type LSH in Lsh−/−
clonal MEF lines expressing either non-silencing shRNA (shNS) or shRNA targeting DNMT3B (sh2 D3B). HDAC1 and MRE11 were used as loading
controls. (C) Bisulfite DNA sequencing of IAPs and the promoters ofRhox2a andRhox6 genes in indicated cell lines. Methylated CpGs are shown in black.
(D) Expression relative to Gapdh of IAPs, Rhox2a and Rhox6 in indicated cell lines. The expression detected in Lsh−/− MEFs was designated as 1. The
error bars denote standard deviation.
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teracts with DNMT3B and indirectly, via DNMT3B, with
DNMT1 and histone deacetylases HDAC1 and HDAC2
(20), we asked if DNMT3B is responsible for methyla-
tion of repetitive sequences and unique loci in Lsh−/−
LSH MEFs. To address this, we first stably knocked down
DNMT3B in Lsh−/− MEFs by lentiviral vectors express-
ing small hairpin (sh) RNAs (Figure 6A, sh1-3). In parallel,
we established a control cell line carrying a non-silencing
shRNA (Figure 6A, shNS). Although all three shRNA tar-
geting DNMT3B reduced the levels of DNMT3B mRNA
and protein by 60–75% (Figure 6A and B), cells carrying the
most efficient shRNAs (sh1 and sh3) displayed growth in-
hibition and were not used further. We next introduced the
wild-type LSH into the Lsh−/− sh2-D3B and into the con-
trol shNS cells and subsequently established stable clonal
sh2D3B-LSH and shNS-LSH cell lines (Figure 6B).
Analyses of IAPs as well as Rhox2 and Rhox6 pro-
moters by bisulfite DNA sequencing and mRNA levels
by quantitative RT-PCR reveled that while gene silenc-
ing and DNA methylation were established efficiently at
these loci upon expression of LSH in the control Lsh−/−
shNS MEFs, both de novo DNA methylation (Figure 6C)
and transcriptional silencing (Figure 5D) were impaired
in DNMT3B knockdown sh2D3B-LSH MEFs. These ex-
periments demonstrate that the cellular concentration of
DNMT3B is critical for LSH-mediated gene silencing and
de novo DNA methylation in somatic cells.
DISCUSSION
It is well established that early embryogenesis is orches-
trated by morphogen gradients, signaling pathways and
strong transcription factors, which shape the repertoire of
gene expression in differentiating cells. A number of stud-
ies have linked chromatin modifications and DNA methy-
lation to developmental signaling (36) and DNA methy-
lation reprogramming to major developmental transitions
from toti- and pluripotency to developmentally restricted
cell fates (2,3). Given this knowledge, we asked in this study
whether or not de novo DNA methylation can occur in so-
matic cells in the absence of exogenous signals.
The Lsh−/− MEFs are an excellent model to address
this question as it is assumed that in the absence of LSH-
dependent chromatin remodeling a proportion of devel-
opmentally programmed de novo DNA methylation events
have failed to occur in embryos from which these cells are
derived (18,19). Thus, we aimed to determine if restoring
the LSH expression in Lsh−/− MEFs would result in pat-
terns of DNAmethylation that resemble those of their wild-
type counterparts. This is an important question as recently
mutations in LSH were found in a subset of patients with
ICF (Immunodeficiency, Centromeric instability and Fa-
cial anomalies) syndrome (37), a human disease most com-
monly associated with congenital mutations in DNMT3B
(38,39). Thus, addressing the reversibility of DNMT3B and
LSH deficiency-caused phenotypes in differentiated cells is
instrumental to motivate further research into improved
therapies for ICF syndrome patients.
Surprisingly, we found that the expression of LSH in
Lsh−/− MEFs grown in culture for many cell generations
substantially reestablishes DNAmethylation in the absence
of additional signals. We also found that LSH supports
de novo DNA methylation by both DNMT3 paralogues,
DNMT3A and 3B, and that an appropriate cellular concen-
tration of DNMT3B as well as the ability of LSH to bind
and hydrolyse ATP are critical for efficient de novo DNA
methylation at unique and repetitive sequences. The latter is
in agreement with recent reports (25,40) and strongly sug-
gests that chromatin remodeling by LSH is necessary for its
function in DNA methylation and double-strand break re-
pair.
De novo DNMTs display high affinity for chromatin
(34,41) and complex binding patterns across the genome,
which are determined by the CpG density and histone mod-
ifications (15). In contrast, LSH displays low affinity for
DNA/chromatin and a highly dynamic behavior (42). Thus
it is conceivable that the patterns of de novo DNMT occu-
pancy remain unchanged in the Lsh−/− MEFs and that
these patterns and the overall residence time of DNMTs
on chromatin, which might be higher on stably positioned
nucleosomes, could determine the sites where chromatin
remodeling by LSH is needed for efficient de novo DNA
methylation. Such model would explain the accurate, yet
incomplete, reestablishment of DNA methylation patterns
in the Lsh−/− MEFs upon LSH re-expression. In agree-
ment with this, we demonstrate that that the appropriate
concentration of DNMT3B is required for LSH-dependent
gene silencing and de novoDNAmethylation. Thus the par-
tial knockdown of DNMT3B in the Lsh−/− MEFs prior
to LSH expression impaired both silencing and de novo
methylation of LSH-dependent loci. Since the expression
of DNMT3A and 3B, but not DNMT1, is downregulated
upon differentiation of embryonic cells (9,19), the low con-
centration of de novo enzymes as well as the absence of
DNMT3L may limit the extent of LSH-mediated reestab-
lishment of DNA methylation in somatic cells. We at-
tempted to overexpress eitherDNMT3Aand 3B inLsh−/−
LSHMEFs, but were unable to isolate stable clones, which
could indicate that somatic cells do not tolerate elevated ex-
pression of de novo DNMTs.
Importantly, the LSH-induced de novo DNA methyla-
tion in Lsh−/− cells occurred at inactive as well as active,
H3K4me3-marked, promoters resulting in stable silencing
of associated genes and transposons, as demonstrated here
for the Rhox loci and IAPs. This raises the question of how
LSH and de novo DNMTs are recruited to active promot-
ers. As the binding of DNMT3A and 3B to the N-terminus
of H3 is inhibited by the presence H3K4 di- and trimethyla-
tion (34,41), it seems unlikely that the recruitment of LSH
to active promoters is directed by either of the twoDNMT3
paralogues. Addressing this question requires further stud-
ies in an inducible system that would enable controlled re-
expression of LSH in theLsh−/−MEFs and detailed inves-
tigation of chromatin dynamics, transcriptional silencing
and the establishment of de novo DNA methylation follow-
ing LSH induction. In parallel, a better characterization of
LSH-associated proteins may also shed light on the mecha-
nisms that govern the establishment of LSH-dependent het-
erochromatin.
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